We explain the advantages of VHHs for CAR ectodomain targeting relative to traditional scFvs including size, solubility, and VHHs unique “magic finger” CDR3 domain.
Advantages of using VHH antibodies for CAR engineering
read more
Technical Resources
A selection of technical resources.
Neurodegenerative Diseases
The advantages of VHH in Neurodegenerative Diseases.
Whitepaper: Clinical landscape for VHHs in immunotherapies
This whitepaper summarises the clinical and research landscape for CAR-T and T-cell engaging antibody therapies and show how single domain VHH antibodies can be applied to optimise the next generation of these important new therapeutic modalities.